Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T51487 | Target Info | |||
Target Name | GABA(A) receptor alpha-1 (GABRA1) | ||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-1; GABA(A) receptor subunit alpha-1
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | GABRA1 | ||||
Biochemical Class | Ligand-gated ion channel | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Gamma-aminobutyric acid B receptor (GABBR) | Successful Target | ||||
UniProt ID | GABR1_HUMAN; GABR2_HUMAN | |||||
Gene Name | GABBR1; GABBR2 | |||||
Synonyms |
Gamma-aminobutyric acid type B receptor; GPRC3; GABABR; GABA-BR; GABA-B-R; GABA-B receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | GSK683699 | Drug Info | IC50 = 25 nM | [1] | ||
Co-Target Name | GABA(A) receptor alpha-3 (GABRA3) | Successful Target | ||||
UniProt ID | GBRA3_HUMAN | |||||
Gene Name | GABRA3 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-3; GABA-A receptor alpha 3; GABA(A)Gamma-aminobutyric-acid receptor alpha-3 subunit precursor receptor; GABA(A) receptor subunit alpha-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Zolpidem | Drug Info | Ki = 400 nM | [2] | ||
Co-Target Name | GABA(A) receptor alpha-2 (GABRA2) | Successful Target | ||||
UniProt ID | GBRA2_HUMAN | |||||
Gene Name | GABRA2 | |||||
Synonyms |
GABRA2; GABA-A receptor alpha 2; GABA(A)Gamma-aminobutyric-acid receptor alpha-2 subunit precursor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Zolpidem | Drug Info | EC50 = 737 nM | [3] | ||
Co-Target Name | GABA transporter-3 (SLC6A11) | Clinical trial Target | ||||
UniProt ID | S6A11_HUMAN | |||||
Gene Name | SLC6A11 | |||||
Synonyms |
Solute carrier family 6 member 11; Sodium- and chloride-dependent GABA transporter 3; GAT3; GAT-3; GABT3
Click to Show/Hide
|
|||||
Representative Drug(s) | GSK683699 | Drug Info | IC50 = 1000 nM | [4] | ||
Co-Target Name | GABA(A) receptor rho1 (GABRR1) | Literature-reported Target | ||||
UniProt ID | GBRR1_HUMAN | |||||
Gene Name | GABRR1 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit rho-1; GABA(C) receptor1; GABA(A) receptor subunit rho-1
Click to Show/Hide
|
|||||
Representative Drug(s) | GSK683699 | Drug Info | EC50 = 269.15 nM | [5] | ||
Co-Target Name | Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) | Literature-reported Target | ||||
UniProt ID | S6A12_HUMAN | |||||
Gene Name | SLC6A12 | |||||
Synonyms |
Solute carrier family 6 member 12; Sodium- and chloride-dependent betaine transporter; BGT-1
Click to Show/Hide
|
|||||
Representative Drug(s) | GSK683699 | Drug Info | IC50 = 851.14 nM | [4] | ||
Co-Target Name | GABA A receptor alpha-2/beta-3/gamma-2 (GABRA2/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA2_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA2-GABRB3-GABRG2 | |||||
Representative Drug(s) | ZK-93423 | Drug Info | Ki = 4.2 nM | Click to Show More | [6] | |
2 | Zolpidem | Drug Info | Ki = 103 nM | [9] | ||
Co-Target Name | GABA A receptor alpha-5/beta-3/gamma-2 (GABRA5/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA5_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA5-GABRB3-GABRG2 | |||||
Representative Drug(s) | ZK-93423 | Drug Info | Ki = 4.5 nM | [7] | ||
Co-Target Name | GABA A receptor alpha-3/beta-3/gamma-2 (GABRA3/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA3_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA3-GABRB3-GABRG2 | |||||
Representative Drug(s) | ZK-93423 | Drug Info | Ki = 6 nM | Click to Show More | [6] | |
2 | Zolpidem | Drug Info | Ki = 246 nM | [9] | ||
3 | Zaleplon | Drug Info | EC50 ~ 1000 nM | [14] | ||
Co-Target Name | GABA-A receptor alpha-4/beta-3/delta (GABRA4/GABRB3/GABRD) | Co-Target | ||||
UniProt ID | GBRA4_HUMAN-GBRB3_HUMAN-GBRD_HUMAN | |||||
Gene Name | GABRA4-GABRB3-GABRD | |||||
Representative Drug(s) | Allopregnanolone | Drug Info | EC50 = 75.5 nM | [8] | ||
Co-Target Name | GABA A receptor alpha-2/beta-2/gamma-2 (GABRA2/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA2_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA2-GABRB2-GABRG2 | |||||
Representative Drug(s) | Zolpidem | Drug Info | EC50 = 180 nM | Click to Show More | [10] | |
2 | GSK683699 | Drug Info | EC50 = 650 nM | [12] | ||
Co-Target Name | GABA A receptor alpha-5/beta-2/gamma-2 (GABRA5/GABRB2/GABRD2) | Co-Target | ||||
UniProt ID | GBRA5_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA5-GABRB2-GABRG2 | |||||
Representative Drug(s) | GSK683699 | Drug Info | EC50 = 230 nM | [11] | ||
Co-Target Name | GABA A receptor alpha-3/beta-2/gamma-2 (GABRA3/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA3_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA3-GABRB2-GABRG2 | |||||
Representative Drug(s) | GSK683699 | Drug Info | EC50 = 912.01 nM | Click to Show More | [5] | |
2 | Zolpidem | Drug Info | Ki = 975 nM | [13] | ||
Co-Target Name | GABA A receptor alpha-5/beta-3/gamma-3 (GABRA5/GABRB3/GABRD3) | Co-Target | ||||
UniProt ID | GBRA5_HUMAN-GBRB3_HUMAN-GBRG3_HUMAN | |||||
Gene Name | GABRA5-GABRB3-GABRG3 | |||||
Representative Drug(s) | Zaleplon | Drug Info | EC50 ~ 1000 nM | [14] | ||
Co-Target Name | GABA A receptor alpha-6/beta-3/gamma-2 (GABRA6/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA6_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA6-GABRB3-GABRG2 | |||||
Representative Drug(s) | ZK-93423 | Drug Info | Ki ~ 1000 nM | [7] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists. J Med Chem. 1995 Aug 18;38(17):3297-312. | ||||
REF 2 | Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases. Eur J Med Chem. 2019 Nov 1;181:111569. | ||||
REF 3 | Synthesis and biological evaluation of 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimdin-5(6H)-ones as functionally selective ligands of the benzodiazepine receptor site on the GABA(A) receptor. J Med Chem. 2002 Nov 7;45(23):5043-51. | ||||
REF 4 | Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/-Aminobutyric Acid Transporter 1 (BGT1). J Med Chem. 2017 Nov 9;60(21):8834-8846. | ||||
REF 5 | Synthesis and biological evaluation of 4-(aminomethyl)-1-hydroxypyrazole analogues of muscimol as -aminobutyric acid(a) receptor agonists. J Med Chem. 2013 Feb 14;56(3):993-1006. | ||||
REF 6 | Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) a... J Med Chem. 1998 Jul 2;41(14):2537-52. | ||||
REF 7 | Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach. J Med Chem. 2000 Jan 13;43(1):71-95. | ||||
REF 8 | Neuroactive Steroids. 2. 3alpha-Hydroxy-3beta-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5beta-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (gamma-Aminobutyric Acid)?A?Receptor. J Med Chem. 2017 Sep 28;60(18):7810-7819. | ||||
REF 9 | Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit. J Med Chem. 2005 Mar 10;48(5):1367-83. | ||||
REF 10 | Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new se... J Med Chem. 1997 Sep 12;40(19):3109-18. | ||||
REF 11 | Five-Membered N-Heterocyclic Scaffolds as Novel Amino Bioisosteres at gamma-Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters. J Med Chem. 2019 Jun 27;62(12):5797-5809. | ||||
REF 12 | Synthesis and pharmacological evaluation of 6-aminonicotinic acid analogues as novel GABA(A) receptor agonists. Eur J Med Chem. 2014 Sep 12;84:404-16. | ||||
REF 13 | Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem. 2008 Nov 27;51(22):7243-52. | ||||
REF 14 | Ion channels as therapeutic targets: a drug discovery perspective. J Med Chem. 2013 Feb 14;56(3):593-624. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.